Skip to Content

277 (Januvia 100 mg)

Generic Name: sitagliptin

Pill with imprint 277 is Brown, Round and has been identified as Januvia 100 mg. It is supplied by Merck & Company Inc..

Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 277

Januvia 100 mg 277
Januvia 100 mg 277  Front
Januvia 100 mg 277  Back
Januvia 100 mg 277  Front
Januvia 100 mg 277  Back
Januvia 100 mg 277

Januvia

Generic Name:
sitagliptin
Imprint:
277
Strength:
100 mg
Color:
Brown
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Merck & Company Inc.
Inactive Ingredients:
calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54569-5925 A-S Medication Solutions, LLC (repackager)
54868-5840 Physicians Total Care Inc (repackager)
35356-0103 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide